Anders Hedlund

Director Ejecutivo en PERPETUA MEDICAL AB .

Finance

Consumer Services

Electronic Technology

Perfil

Anders Hedlund is the founder of Nolsterby Invest AB, established in 2021, where the title held is Chief Executive Officer.
The current job is Chief Executive Officer & Director at Perpetua Medical AB, starting in 2024.
Former job includes Equity Analyst at Redeye AB from 2017 to 2021.
Education includes a graduate degree from the University of Uppsala, conferred in 2010.

Cargos activos de Anders Hedlund

Empresas	Cargo	Inicio
PERPETUA MEDICAL AB	Director Ejecutivo	01/05/2024
Nolsterby Invest AB Nolsterby Invest AB Investment ManagersFinance Nolsterby Invest invests in companies located in Sweden. The firm focuses on medtech, diagnostics, biotech, life science tools & supplies, and healthtech. It participates in growth stage capital requirements.	Director Ejecutivo	01/08/2021

Todos los cargos activos de Anders Hedlund

Antiguos cargos conocidos de Anders Hedlund.

Empresas	Cargo	Fin
Redeye AB Redeye AB Investment ManagersFinance Provides investment research	Analyst-Equity	01/08/2021

Ver el detalle de la experiencia de Anders Hedlund.

Formación de Anders Hedlund.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Anders Hedlund.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	4
University of Uppsala University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Redeye AB Redeye AB Investment ManagersFinance Provides investment research	Finance
Perpetua Medical AB Perpetua Medical AB Electronic Equipment/InstrumentsElectronic Technology Manufactures pharmacological measurements systems	Electronic Technology
Nolsterby Invest AB Nolsterby Invest AB Investment ManagersFinance Nolsterby Invest invests in companies located in Sweden. The firm focuses on medtech, diagnostics, biotech, life science tools & supplies, and healthtech. It participates in growth stage capital requirements.	Finance